Italia markets closed

Spyre Therapeutics, Inc. (SYRE)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
23,51+0,80 (+3,52%)
Alla chiusura: 04:00PM EDT
23,51 0,00 (0,00%)
Dopo ore: 04:45PM EDT
Maggiori azionisti
Elenco insider

Transazioni interne

Valuta in USD
Acquisti degli insider negli ultimi 6 mesiAzioniTrans
Acquisti00
VenditeN/D0
Saldo azioni acquistate (vendute)00
Totale di azioni possedute dagli insider1,59MN/D
% saldo azioni acquistate (vendute)N/DN/D
Acquisti al netto degli investitori istituzionali del trimestre precedente fino all'ultimo trimestreAzioni
Saldo azioni acquistate (vendute)N/D
% variazione nelle azioni possedute da investitori istituzionaliN/D

Compravendite insider riportate - ultimi due anni

InsiderTransazioneTipoValoreDataAzioni

TURTLE CAMERON
Chief Executive Officer

Stock Award(Grant) at price 22.56 per share.Diretto9.02415 feb 2024400

BURROWS SCOTT L.
Chief Financial Officer

Stock Award(Grant) at price 0.00 per share.Diretto022 dic 2023134.953

ALBERS JEFFREY W
Director

Indiretto24 nov 202334.360

TURTLE CAMERON
Chief Executive Officer

Diretto24 nov 2023723.440

FAIRMOUNT FUNDS MANAGEMENT LLC
Beneficial Owner of more than 10% of a Class of Security

Indiretto24 nov 20233.435.480

SOUZA MARCIO SILVA DE
Director

Purchase at price 0.56 per share.Diretto50.47225 ago 202290.000

HANLEY MICHAEL CONICK JR.
Officer

Purchase at price 0.71 per share.Diretto20.02208 giu 202228.200

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 2.34 per share.Diretto187.70516 mar 202280.079

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 1.86 - 2.06 per share.Diretto280.94315 mar 2022144.666

ALSPAUGH JONATHAN D.
Chief Financial Officer

Purchase at price 2.08 per share.Diretto156.00011 mar 202275.000

SHANAFELT ARMEN B
Director

Purchase at price 3.65 - 3.67 per share.Diretto549.69213 dic 2021150.000

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 3.70 - 3.75 per share.Diretto198.97210 dic 202153.634

ALSPAUGH JONATHAN D.
Chief Financial Officer

Purchase at price 3.72 per share.Diretto186.00009 dic 202150.000

QUINN ANTHONY G
Chief Executive Officer

Stock Gift at price 0.00 per share.Diretto020 ott 2021266.295

ALSPAUGH JONATHAN D.
Chief Financial Officer

Purchase at price 6.37 - 6.72 per share.Diretto262.66018 ago 202140.372

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 7.77 per share.Diretto1.282.05030 apr 2020165.000

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 5.46 - 6.31 per share.Diretto114.68904 ott 201918.265

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 6.11 - 6.23 per share.Diretto196.45314 giu 201931.905

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 6.55 - 6.89 per share.Diretto180.03222 mag 201926.592

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 6.65 - 7.10 per share.Diretto126.39917 mag 201918.713

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 5.46 - 6.31 per share.Diretto54.12606 feb 20198.756

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 4.11 - 6.31 per share.Diretto751.81607 dic 2018171.890

SCHUCHART AARON
Officer

Sale at price 9.50 - 9.55 per share.Diretto57.00527 set 20186.000

SCHUCHART AARON
Officer

Conversion of Exercise of derivative security at price 3.50 per share.Diretto29.75017 ago 20188.500

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 6.02 - 9.13 per share.Diretto21.11515 ago 20182.994

GEORGIOU GEORGE
Director

Conversion of Exercise of derivative security at price 4.73 - 7.28 per share.Diretto220.78413 ago 201837.333

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 6.31 - 7.04 per share.Diretto262.76412 lug 201838.866

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 5.46 per share.Diretto18.05611 lug 20183.307

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 10.06 per share.Indiretto196.67311 mag 201819.550

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 10.11 - 10.13 per share.Indiretto748.14010 mag 201873.955

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Sale at price 10.03 - 10.11 per share.Diretto423.55708 mag 201842.105

QUINN ANTHONY G
Chief Executive Officer

Conversion of Exercise of derivative security at price 5.46 per share.Diretto83.05215 feb 201815.211

QUINN ANTHONY G
Chief Executive Officer

Purchase at price 4.92 - 5.07 per share.Diretto41.07808 dic 20178.288

QUINN ANTHONY G
Director

Purchase at price 4.53 - 4.98 per share.Diretto83.17705 dic 201717.121

YORK CHARLES N. II CPA
Chief Financial Officer

Purchase at price 2.52 - 4.97 per share.Diretto116.22305 dic 201725.959

ORBIMED ADVISORS, L.L.C.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 5.04 - 5.36 per share.Indiretto563.88221 feb 2017109.300

ELI LILLY & CO
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 10.00 per share.Indiretto5.000.00012 apr 2016500.000

ELI LILLY & CO
Beneficial Owner of more than 10% of a Class of Security

Indiretto12 apr 20162.010.924

TYLER JOSEPH E
Officer

Diretto12 apr 201631.260

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Purchase at price 10.00 per share.Indiretto3.000.00012 apr 2016300.000

NOVARTIS BIOVENTURES, LTD.
Beneficial Owner of more than 10% of a Class of Security

Indiretto12 apr 20162.010.924

LOWE DAVID GEORGE
Chief Executive Officer

Indiretto12 apr 20165.658

COX RUSSELL J
Director

Purchase at price 10.00 per share.Diretto70.00012 apr 20167.000

QUINN ANTHONY G
Director

Purchase at price 10.00 per share.Diretto100.00012 apr 201610.000

YORK CHARLES N. II CPA
Chief Financial Officer

Indiretto12 apr 201612.884

ROWLINSON SCOTT W
Officer

Indiretto12 apr 201611.204